Tag: plans

SHANGHAI, July 30, 2025 /PRNewswire/ -- From July 26 to 28, the 2025 World Artificial Intelligence Conference (WAIC) convened in Shanghai under the theme "Global...

BALA CYNWYD, Pa., July 29, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced the pricing of its previously announced underwritten public offering of 18,750,000 shares of its common stock at a price to the public of $3.20 per share. The aggregate gross proceeds to Larimar from this offering are expected to be $60.0 million, before deducting underwriting discounts and commissions and other offering expenses. In addition, Larimar has granted the underwriters a 30-day option to purchase up to an additional 2,812,500 shares of its common stock at the public offering price, less underwriting discounts and commissions. All shares of common stock are being offered by Larimar. The offering is expected to close on or about July 31, 2025, subject to the satisfaction of customary closing conditions.

SHANGHAI, July 30, 2025 /PRNewswire/ -- From July 26 to 28, the 2025 World Artificial Intelligence Conference (WAIC) convened in Shanghai under the theme "Global...

SHANGHAI, July 29, 2025 /PRNewswire/ -- From July 26 to 28, the 2025 World Artificial Intelligence Conference (WAIC) convened in Shanghai under the theme "Global...

SHANGHAI, July 29, 2025 /CNW/ -- From July 26 to 28, the 2025 World Artificial Intelligence Conference (WAIC) convened in Shanghai under the theme "Global...

NEW YORK, July 29, 2025 /PRNewswire/ -- The rising summer heat presents new challenges for individuals with respiratory conditions. To help meet these seasonal...

IRVINE, Calif., July 29, 2025 /PRNewswire/ -- BrainStorm STEM Education is proud to announce that it has been awarded a nationally recognized contract with...

TSX-V: MSR TORONTO, July 29, 2025 /CNW/ - Minsud Resources Corp. (TSXV: MSR) ("Minsud" or the "Company"), is pleased to announce the significant results received from its...

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ SASKATOON, SK, July 29, 2025 /CNW/ - ZYUS Life Sciences...

NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- The meme-powered crypto project Troller Cat ($TCAT) has entered the 15th and final stages of its presale, raising more than $425,000 and attracting over 1,600 token holders to date. With a listing price set at $0.0005309, Stage 15 tokens are currently available at $0.0001063, offering a potential value gap that has contributed to renewed market interest.

New Non-Stimulant Supplement Aims to Complement Overnight Wellness Routines with Polyamine-Aligned Botanical Support

New Non-Stimulant Supplement Aims to Complement Overnight Wellness Routines with Polyamine-Aligned Botanical Support

Salt Lake City, July 29, 2025 (GLOBE NEWSWIRE) -- BluSky AI Inc., a leading innovator in modular AI infrastructure, is proud to announce the signing of a Letter of Intent (LOI) to purchase approximately 15 acres of industrial land in Camp Verde, Arizona. The site includes existing electrical infrastructure capable of supporting 1.75 megawatts (MW), with plans to expand to 3.75 MW to meet growing demand.

MELBOURNE, Australia and INDIANAPOLIS, July 30, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today advises that it will release its financial...